As GLP-1 therapies transform obesity management, they are also reshaping the way people eat, think about nutrition, and manage their long-term health. In South Africa, rapid growth in GLP-1 adoption is driving new consumer needs around nutrient density, protein intake, muscle preservation, gastrointestinal health, supplementation, and sustainable weight management. This report explores how the rise of GLP-1s is creating new opportunities across nutrition, Consumer Health, pharmacy, and healthcare support services.

Drawing on global evidence, South African market data, and consumer social intelligence, IQVIA examines the evolving nutrition landscape surrounding GLP-1 therapies and highlights the emerging trends, opportunities, and implications for stakeholders seeking to support patients beyond the medicine itself.